As the demands of clinical development change, being nimble and adaptable becomes more critical. Meeting the evolving needs of multiple stakeholders ultimately determines the probability of success. And new agile development models are required to meet customer needs and increasing competitive intensity. Innovative technologies allow pharma companies to explore and pursue patient-centric approaches to trial execution and data collection in ways that were previously cost-prohibitive.